ArticleScientific reports2017

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m.

Javad Garousi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.